GlassScriptPhysician profile
Mahir Patel
NPI 1417191917
$9,483.00
in general payments reported to CMS, 2019-2025
40 companies · $2,616 in 2025
The $2,616 reported for 2025 was more than what 82% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,348 · 2020: $346 · 2021: $507 · 2022: $883 · 2023: $1,460 · 2024: $2,323 · 2025: $2,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,917 · Education: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,916.88 |
| Education | $481.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,579.91 | 2019-2025 | |
| Lilly USA, LLC | $884.35 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $807.37 | 2019-2025 | Blu-U, Odomzo, Ilumya |
| Regeneron Healthcare Solutions, INC. | $800.43 | 2019-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $768.14 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $662.12 | 2019-2025 | |
| Incyte Corporation | $609.23 | 2021-2025 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $400.27 | 2019-2025 | Jublia, Cabtreo, Arazlo |
| Botanix Sb INC | $375.59 | 2025 | Sofdra |
| Amgen INC. | $298.94 | 2019-2025 | Otezla, Otezla |
| Leo Pharma INC. | $272.57 | 2019-2024 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $251.58 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $247.84 | 2019-2025 | |
| Pfizer INC. | $242.85 | 2019-2025 | |
| Galderma Laboratories, L.P. | $150.23 | 2019-2025 | Nemluvio, Aklief |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahir Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.